Cellectis S.A.
Cellectis S.A.
CLLS
Valuace
100
Růst
86
Zdraví
75
Cena
$ 3.55
Dnes
--0.02 (-0.37%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.4B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-5
PS
5
Cena 1R
1-5
⌀ Cena
2.85
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-03-2026
Poslední dividenda

Profil

Cellectis S.A., biotechnologická společnost v klinickém stadiu, vyvíjí imuno-onkologické produkty založené na genově editovaných T-buňkách, které exprimují chimerické antigenové receptory pro cílení a eradikaci nádorových buněk. Působí ve dvou segmentech, Therapeutics a Plants. Společnost vyvíjí UCART19, allogenní kandidát na produkt T-buněk pro léčbu hematologických malignit exprimujících CD19, jako je akutní lymfoblastická leukémie; ALLO-501 a ALLO-501A pro léčbu relabujícího/refrakterního difuzního velkobuněčného B lymfomu a folikulárního lymfomu; ALLO-316 pro léčbu renálního karcinomu; UCART123 pro léčbu akutní myeloidní leukémie; a UCART22 pro léčbu akutní lymfoblastické leukémie B buněk. Vyvíjí se také UCARTCS1 a ALLO-715 pro léčbu mnohočetného myelomu. Společnost má strategické aliance s Allogene Therapeutics, Inc., Les Laboratoires Servier, Texaskou univerzitou M.D. Anderson Cancer Center a Iovance Biotherapeutics, stejně jako strategickou výzkumnou a vývojovou spolupráci s Cytovia Therapeutics, Inc. Cellectis S.A. byla založena v roce 1999 a sídlí v Paříži ve Francii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
216
Založení
2015-03-24
Adresa
8, rue de la Croix Jarry
CEO
Andre Choulika

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues73.273.241.50.819.273.973.915.212.725.242.655.026.322.827.820.721.0
Cost of Revenues11.920.19.20.71.836.336.311.42.72.61.72.73.70.82.03.31.9
Gross Profit61.053.132.30.017.437.737.73.810.022.640.952.322.622.025.817.519.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues10.635.216.710.712.716.28.14.50.30.2
Cost of Revenues5.12.42.42.02.52.81.52.35.30.2
Gross Profit5.332.814.38.610.213.46.52.2-5.10.0
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.087.697.587.087.092.076.679.274.657.317.534.425.115.916.4
Selling General & Admin Expenses0.00.00.016.817.544.244.243.047.244.841.329.815.930.525.826.717.9
Depreciation & Amortization20.120.119.818.518.416.69.86.92.43.42.11.91.745.90.00.81.6
Total Operating Expenses95.693.591.997.3107.1123.1123.1127.4115.1115.2104.982.929.067.151.942.834.3
Operating Income-40.5-40.5-59.6-106.6-89.7-85.4-85.4-123.6-105.1-92.7-64.0-30.5-6.4-80.6-26.1-25.3-15.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.025.518.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.21.6
Depreciation & Amortization5.25.05.04.95.84.74.74.65.24.5
Total Operating Expenses24.124.823.922.820.924.223.723.125.720.6
Operating Income-24.88.0-9.6-14.2-10.7-10.8-17.2-20.9-30.7-20.7
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income9.59.511.33.61.10.71.98.316.8-11.00.08.30.40.4-1.70.80.6
Interest Expense8.18.17.56.43.85.312.02.60.00.00.00.00.20.4-1.70.60.2
Other Expense-34.4-34.422.8-16.4-8.9-12.0-12.08.310.5-16.50.67.18.5-35.9-1.70.20.5
IBT-74.9-74.9-36.8-123.0-98.6-97.5-97.5-115.2-88.3-103.7-63.9-22.32.3-81.1-27.9-25.1-14.8
Income Tax Expense-2.2-7.10.0-6.20.1-11.2-24.9-24.516.8-13.2-1.5-0.92.44.71.65.8-4.0
Net Income-67.6-67.8-36.8-101.1-98.7-86.3-72.6-90.7-78.7-99.4-63.9-22.50.0-84.3-29.5-30.9-10.7
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income2.12.32.22.93.53.02.81.91.50.7
Interest Expense2.02.12.11.91.72.11.81.81.51.5
Other Expense-8.9-7.5-14.1-3.917.1-12.3-8.326.3-34.83.3
IBT-33.60.6-23.7-18.16.4-23.1-25.55.4-64.4-17.4
Income Tax Expense-2.20.00.00.00.5-0.1-0.2-0.3-0.70.1
Net Income-26.30.6-23.7-18.15.9-23.1-25.35.6-42.9-17.5
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.77$-2.17$-1.93$-1.71$-2.14$-1.93$-2.78$-1.81$-0.66$0.00$-4.08$-1.48$-2.19$-0.76
EPS Diluted$0.00$0.00$0.00$-1.77$-2.17$-1.93$-1.71$-2.14$-1.93$-2.78$-1.78$-0.65$0.00$-4.08$-1.48$-2.19$-0.76
Shares Outstanding100.3100.390.657.045.544.842.542.440.835.735.334.126.120.719.914.114.1
Diluted Shares Outstanding100.3100.390.657.045.544.842.542.440.835.735.834.526.220.719.914.114.1
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.60$-0.31
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.60$-0.31
Shares Outstanding100.3100.3100.3100.2100.1100.189.971.871.855.6
Diluted Shares Outstanding100.3100.3100.3100.2100.1100.189.9103.171.855.6
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents149.0143.3136.797.7186.1268.2360.9451.9297.0290.5343.6136.610.428.854.932.0
Short Term Investments123.8117.167.17.90.527.120.40.440.636.50.00.00.00.00.00.0
Total Cash & ST Investments272.8260.3203.897.7186.1268.2360.9451.9297.0290.5343.6136.610.428.854.932.0
Accounts Receivable26.423.023.115.329.615.912.120.112.312.316.519.616.121.711.012.1
Inventory0.00.00.021.80.01.62.90.30.30.10.20.20.50.90.80.2
Other Current Assets6.63.76.19.19.729.615.615.313.78.85.11.80.50.03.93.3
Total Current Assets305.8287.1233.0143.8225.4315.4391.5487.6323.2311.8365.4160.527.551.570.647.6
Current Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Cash And Equivalents59.8127.6143.3159.1149.0123.0136.767.485.583.5
Short Term Investments136.3114.1117.1101.8123.726.267.10.01.14.6
Total Cash & ST Investments196.2241.7260.3260.9272.7149.2203.867.485.588.2
Accounts Receivable29.425.523.027.926.440.423.122.021.021.9
Inventory0.00.00.00.00.00.00.06.90.027.0
Other Current Assets5.14.63.75.66.668.66.17.26.827.3
Total Current Assets230.6271.8287.1294.4305.7258.1233.096.5113.3137.4
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment84.075.992.7107.9148.3145.569.310.07.216.95.53.25.37.38.65.2
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.01.50.00.00.0
Intangible Assets0.71.10.70.71.91.61.11.31.41.31.01.27.650.045.65.3
Long-Term Investments6.97.57.98.86.57.05.51.91.00.70.92.42.11.91.20.3
Other Long-Term Assets9.811.60.00.00.00.05.50.00.00.00.00.00.00.00.00.0
Total Long-Term Assets101.396.5101.3117.4156.6154.175.913.29.718.97.56.816.663.661.321.7
Total Assets407.1383.5334.3261.2382.1469.5467.5500.8332.9330.7372.9167.344.1115.1131.969.2
Long-Term Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Net Property, Plant & Equipment70.272.975.981.284.087.892.795.9100.7105.1
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets1.20.21.10.70.70.70.70.70.70.7
Long-Term Investments1.92.07.52.22.22.37.911.213.08.2
Other Long-Term Assets49.716.711.616.64.74.77.94.70.80.0
Total Long-Term Assets123.392.396.5101.4101.396.4101.3113.2114.4114.0
Total Assets354.0364.1383.5395.9407.1354.5334.3209.7227.7251.4
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable18.218.719.121.523.824.629.315.99.59.77.211.913.027.025.411.3
Short-Term Debt13.513.213.713.010.76.71.10.30.01.72.11.01.01.31.60.7
Other Current Liabilities10.222.212.128.514.620.312.29.98.05.814.95.710.50.00.00.3
Current Liabilities159.6166.3155.163.049.352.062.646.943.556.084.191.032.228.427.017.0
Current Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Accounts Payable17.517.218.718.518.216.119.120.519.222.3
Short-Term Debt12.912.913.213.713.313.413.713.113.313.2
Other Current Liabilities23.519.122.210.6126.98.312.110.29.224.6
Current Liabilities167.4162.6166.3165.7159.6158.4155.144.042.060.5
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt58.378.271.469.991.6104.646.51.00.00.00.13.44.74.467.51.1
Capital Leases38.442.651.557.279.982.547.61.40.00.10.20.41.20.00.00.0
Def. Tax Liability0.00.00.20.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities258.5252.5249.6135.3145.6160.6112.050.647.056.684.795.037.533.494.919.1
Long-Term Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Long-Term Debt81.878.978.277.877.980.871.470.886.460.9
Capital Leases39.741.042.645.246.749.042.952.054.456.5
Def. Tax Liability0.00.00.00.10.00.00.20.00.00.0
Total Liabilities256.9247.9252.5266.5258.5263.9249.6133.6131.1130.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock5.95.94.43.02.92.82.82.82.41.91.91.81.5174.6104.20.8
Retained Earnings-425.4-329.6-405.8-439.5-698.3-587.0-508.5-405.3-351.3-229.8-172.40.0-84.3-28.9-67.2-10.7
Comprehensive Income-38.1-39.5-36.7-28.6-18.0-4.1-22.6-16.72.02.6-1.8-162.1-94.2-66.70.00.0
Total Common Equity148.6131.084.7118.0221.3275.6315.1409.3266.8272.2287.473.96.978.937.050.1
Total Common Equity 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Common Stock5.95.95.95.95.94.44.43.53.53.5
Retained Earnings-308.5-347.7-329.6-448.5-425.4-400.2-405.8-363.2-346.1-469.3
Comprehensive Income-33.9-37.3-39.5-35.2-38.1-37.2-36.7-37.5-37.1-28.5
Total Common Equity97.1116.2131.0129.4148.690.684.776.196.6113.7
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt110.291.592.982.8102.2111.347.61.40.01.82.24.55.65.769.11.8
Book Value148.6131.084.7125.9236.5308.8355.5450.3285.9274.0288.272.46.781.737.050.1
Other 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Total Debt0.00.00.00.00.00.00.00.00.06.8
Book Value97.1116.2131.0129.4148.690.684.776.196.6113.7
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-98.7-67.8-36.7-116.8-98.7-125.1-97.5-115.2-88.3-103.7-63.9-22.32.2-85.8-29.5-30.9-10.7
Depreciation & Amortization18.920.119.818.518.416.69.86.92.43.42.11.91.745.90.00.01.6
Stock-Based Compensation3.70.00.05.26.013.116.726.937.250.455.732.90.7-0.10.00.00.6
Change Working Capital111.9-41.753.6-4.0-5.7-4.2-21.811.7-9.1-17.8-24.9-1.555.78.6-6.75.2-8.7
Change In Accounts Receivable40.7-4.4-6.72.3-3.2-5.8-8.3-2.7-3.7-0.5-0.91.2-8.50.00.00.00.0
Change In Accounts Payable0.5-3.32.1-6.33.2-0.45.89.69.4-0.3-4.22.9-0.80.00.00.00.0
Change In Inventories-1.50.00.00.00.01.61.3-2.60.0-0.10.00.00.10.50.00.00.0
Other Non-cash Items11.649.3-14.671.9-7.6-5.612.0-8.3-16.811.0-1.4-7.5-9.01.110.012.50.2
Cash from Operations51.00.00.0-24.7-87.4-104.6-80.3-69.1-68.1-52.3-31.13.550.7-25.6-26.1-13.2-21.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-26.30.6-23.7-18.15.9-23.1-25.35.6-61.6-17.5
Depreciation & Amortization5.15.05.04.95.84.74.74.65.24.5
Stock-Based Compensation0.00.01.31.00.90.60.80.94.6-2.7
Change Working Capital-1.31.7-12.3-11.25.3-3.761.0-8.959.00.7
Change In Accounts Receivable-6.03.7-3.4-1.63.30.459.7-15.7-6.7-0.5
Change In Accounts Payable2.50.00.0-6.33.0-0.25.2-5.9-1.82.9
Change In Inventories0.00.00.00.00.00.00.00.00.0-1.5
Other Non-cash Items12.1-8.819.46.3-17.915.711.1-25.355.9-2.3
Cash from Operations0.00.00.00.00.00.00.00.039.6-17.1
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-1.8-3.5-3.8-1.1-2.4-19.7-46.3-13.0-4.9-2.7-13.3-4.3-0.4-1.9-5.5-4.2-6.7
Acquisitions0.00.00.00.00.00.00.00.00.00.0-0.3-3.10.60.00.00.00.0
Investments-120.6-160.3-162.50.00.00.0-8.10.00.0-2.7-37.4-0.30.00.00.00.00.0
Sales of Investment0.0134.263.70.00.10.00.00.039.20.00.20.00.00.00.00.00.0
Other Investing Activities0.00.00.0-14.4-0.427.00.1-22.91.37.20.30.0-1.8-0.2-0.6-25.21.0
Cash from Investing-122.40.00.0-15.5-2.87.3-54.3-35.935.61.8-50.5-7.6-1.6-2.1-6.1-29.4-5.7
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.5-1.2-0.3-0.4-0.6-0.8-1.0-0.2-0.3-0.3
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments-7.10.0-144.1-5.0-64.08.4-105.4-1.8-13.40.0
Sales of Investment30.10.091.79.749.10.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.0-13.7-0.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-20.50.00.024.6-12.4-12.5-6.6-3.4-0.10.0-0.1-0.6-1.3-0.50.00.0-1.3
Debt Issued30.891.5-1.434.6-7.03.470.349.61.4-1.7-0.3-1.70.10.5-63.467.33.1
Issuance of Common Stock127.20.00.067.90.048.59.20.0236.641.30.7236.472.88.03.62.20.1
Repurchase of Common Stock-1.40.00.00.0-0.60.00.0-0.50.00.0-0.10.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities132.40.00.0-9.614.111.524.70.00.00.00.0-18.4-1.10.01.464.20.0
Cash from Financing134.20.00.082.91.147.527.3-3.9236.541.30.5217.470.47.54.966.4-1.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-2.61.7
Debt Issued0.094.83.00.3-0.10.3-3.01.411.5-14.2
Issuance of Common Stock0.00.00.00.00.00.00.00.044.30.1
Repurchase of Common Stock0.00.00.00.00.0-0.20.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.1-0.1
Cash from Financing0.00.00.00.00.00.00.00.041.71.7
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash64.7-79.76.543.5-92.4-55.5-99.4-111.0195.11.8-76.5220.7127.4-19.7-27.223.8-28.0
Closing Cash Balance149.063.6143.3136.793.2185.6241.1340.5451.5256.4254.0343.6136.610.428.854.932.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash9.3-7.6-67.8-15.6-15.810.026.1-13.769.4-17.0
Closing Cash Balance63.652.259.8127.6143.3159.1149.0123.0136.767.4
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow49.2-42.519.5-25.8-89.9-124.3-126.5-82.1-73.0-55.0-44.4-0.750.3-27.5-31.6-17.4-27.8
Real Free Cash Flow45.5-42.519.5-31.1-95.9-137.4-143.3-109.0-110.2-105.4-100.1-33.649.6-27.4-31.6-17.4-28.3
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-11.0-2.8-10.6-17.6-1.8-6.651.1-23.639.3-17.4
Real Free Cash Flow-11.0-2.8-11.9-18.5-2.7-7.250.3-24.534.7-14.8
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-5-6.8-1.4
P/S4.628.49.4
P/B3.52.25.2
P/FCF-7.6-11.5-1.5
Market cap$0.4$0.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %14.1 %0 %
Debt to Income-140.3 %-55.8 %0 %
Debt to Free cash flow-214.7 %-17025.9 %0 %
Interest expense percentage-20.1 %-9.1 %44.7 %
Current ratio1.4 5.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-69.6 %-39.7 %0 %
ROA-19.1 %-20.9 %0 %
CapEx to Revenue3.2 %35.1 %0 %
RaD to Revenue0 %650.4 %0 %
ROEM329,615.9 162772.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin87.6 %40.5 %68.7 %
Operating margin-35.1 %-750 %35.5 %
Net margin-47 %-683.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %4 %0 %
Dividend payout percentage0 %-29.8 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding100.3 mil 48.8 mil
Employee count0.2 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader